Trilogy Evo is a portable life support ventilator platform designed for consistent therapy. Credit: Koninklijke Philips N.V.

Royal Philips has unveiled a new portable life support ventilator platform called Trilogy Evo, which can offer consistent therapy and monitoring.

The new device is intended to provide continuous care for patients with changes in condition or settings.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Trilogy Evo features the company’s sleep and respiratory care cloud-based management system Care Orchestrator. This software solution enables secure storage of prescription and therapy details, allowing coordination of care from hospital to home.

“The new device is intended to provide continuous care for patients with changes in condition or settings.”

Royal Philips Sleep and Respiratory Care business leader John Frank said: “Worldwide, chronic conditions are on the rise, presenting continually growing care challenges. Time and again, we have seen the positive impact that connected care can have not only on patients but on the care teams that serve them.

“With effective treatment options, chronic respiratory conditions can be managed effectively. Trilogy Evo is our next evolution of work in connected care solutions, making therapy management for chronic conditions easier and more efficient.”

The company is presenting the new device at the European Respiratory Society (ERS) International Congress 2018 being held in Paris, France.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

In addition to Trilogy Evo, Philips has decided to showcase the Care Orchestrator and other sleep and respiratory therapy solutions, including NightBalance Luno, SmartSleep and its DreamWear range.

NightBalance Lunoa is a new lightweight device for the treatment of positional sleep apnoea, while SmartSleep is a wearable designed to improve deep sleep quality.

Part of the Philips DreamWear line, the latest DreamWear Full Face is intended to offer freedom of movement for patients.

DreamStation Go is a comparatively smaller CPAP therapy, and DreamMapper is a mobile and web-based application for PAP therapy.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact